AAAAAA

   
Results: 1-25 | 26-50 | 51-63
Results: 1-25/63
CHEMOTHERAPY OF BRAIN-TUMORS
Authors: PRADOS MD RUSSO C
Citation: Md. Prados et C. Russo, CHEMOTHERAPY OF BRAIN-TUMORS, Seminars in surgical oncology, 14(1), 1998, pp. 88-95
GENETIC-ANALYSIS OF GLIOBLASTOMA-MULTIFORME PROVIDES EVIDENCE FOR SUBGROUPS WITHIN THE GRADE
Authors: MOHAPATRA G BOLLEN AW KIM DH LAMBORN K MOORE DH PRADOS MD FEUERSTEIN BG
Citation: G. Mohapatra et al., GENETIC-ANALYSIS OF GLIOBLASTOMA-MULTIFORME PROVIDES EVIDENCE FOR SUBGROUPS WITHIN THE GRADE, Genes, chromosomes & cancer, 21(3), 1998, pp. 195-206
PHASE-I STUDY OF PACLITAXEL IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA - A NORTH-AMERICAN BRAIN-TUMOR CONSORTIUM REPORT
Authors: CHANG SM KUHN JG RIZZO J ROBINS HI SCHOLD SC SPENCE AM BERGER MS MEHTA MP BOZIK ME POLLACK I GILBERT M FULTON D RANKIN C MALEC M PRADOS MD
Citation: Sm. Chang et al., PHASE-I STUDY OF PACLITAXEL IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA - A NORTH-AMERICAN BRAIN-TUMOR CONSORTIUM REPORT, Journal of clinical oncology, 16(6), 1998, pp. 2188-2194
INFLUENCE OF BROMODEOXYURIDINE RADIOSENSITIZATION ON MALIGNANT GLIOMAPATIENT SURVIVAL - A RETROSPECTIVE COMPARISON OF SURVIVAL-DATA FROM THE NORTHERN CALIFORNIA ONCOLOGY GROUP (NCOG) AND RADIATION-THERAPY ONCOLOGY GROUP TRIALS (RTOG) FOR GLIOBLASTOMA, MULTIFORME AND ANAPLASTIC ASTROCYTOMA
Authors: PRADOS MD SCOTT CB ROTMAN M RUBIN P MURRAY K SAUSE W ASBELL S COMIS R CURRAN W NELSON J DAVIS RL LEVIN VA LAMBORN K PHILLIPS TL
Citation: Md. Prados et al., INFLUENCE OF BROMODEOXYURIDINE RADIOSENSITIZATION ON MALIGNANT GLIOMAPATIENT SURVIVAL - A RETROSPECTIVE COMPARISON OF SURVIVAL-DATA FROM THE NORTHERN CALIFORNIA ONCOLOGY GROUP (NCOG) AND RADIATION-THERAPY ONCOLOGY GROUP TRIALS (RTOG) FOR GLIOBLASTOMA, MULTIFORME AND ANAPLASTIC ASTROCYTOMA, International journal of radiation oncology, biology, physics, 40(3), 1998, pp. 653-659
SURVIVAL BENEFIT OF HYPERTHERMIA IN A PROSPECTIVE RANDOMIZED TRIAL OFBRACHYTHERAPY BOOST + - HYPERTHERMIA FOR GLIOBLASTOMA-MULTIFORME/
Authors: SNEED PK STAUFFER PR MCDERMOTT MW DIEDRICH CJ LAMBORN KR PRADOS MD CHANG S WEAVER KA SPRY L MALEC MK LAMB SA VOSS B DAVIS RL WARA WM LARSON DA PHILLIPS TL GUTIN PH
Citation: Pk. Sneed et al., SURVIVAL BENEFIT OF HYPERTHERMIA IN A PROSPECTIVE RANDOMIZED TRIAL OFBRACHYTHERAPY BOOST + - HYPERTHERMIA FOR GLIOBLASTOMA-MULTIFORME/, International journal of radiation oncology, biology, physics, 40(2), 1998, pp. 287-295
RADIATION-THERAPY AND HYDROXYUREA FOLLOWED BY THE COMBINATION OF 6-THIOGUANINE AND BCNU FOR THE TREATMENT OF PRIMARY MALIGNANT BRAIN-TUMORS
Authors: PRADOS MD LARSON DA LAMBORN K MCDERMOTT MW SNEED PK WARA WM CHANG SM MACK EE KROUWER HGJ CHANDLER KL WARNICK RE DAVIS RL RABBITT JE MALEC M LEVIN VA GUTIN PH PHILLIPS TL WILSON CB
Citation: Md. Prados et al., RADIATION-THERAPY AND HYDROXYUREA FOLLOWED BY THE COMBINATION OF 6-THIOGUANINE AND BCNU FOR THE TREATMENT OF PRIMARY MALIGNANT BRAIN-TUMORS, International journal of radiation oncology, biology, physics, 40(1), 1998, pp. 57-63
HIGH-DOSE ORAL TAMOXIFEN AND SUBCUTANEOUS INTERFERON ALPHA-2A FOR RECURRENT GLIOMA
Authors: CHANG SM BARKER FG HUHN SL NICHOLAS MK PAGE M RABBITT J PRADOS MD
Citation: Sm. Chang et al., HIGH-DOSE ORAL TAMOXIFEN AND SUBCUTANEOUS INTERFERON ALPHA-2A FOR RECURRENT GLIOMA, Journal of neuro-oncology, 37(2), 1998, pp. 169-176
PCV CHEMOTHERAPY FOR RECURRENT OLIGODENDROGLIOMAS AND OLIGOASTROCYTOMAS - COMMENT
Authors: PRADOS MD
Citation: Md. Prados, PCV CHEMOTHERAPY FOR RECURRENT OLIGODENDROGLIOMAS AND OLIGOASTROCYTOMAS - COMMENT, Neurosurgery, 43(5), 1998, pp. 1073-1073
LOCAL-DELIVERY OF CHEMOTHERAPY PROLONGS SURVIVAL IN EXPERIMENTAL BRAIN METASTASES FROM BREAST-CARCINOMA - COMMENTS
Authors: PRADOS MD
Citation: Md. Prados, LOCAL-DELIVERY OF CHEMOTHERAPY PROLONGS SURVIVAL IN EXPERIMENTAL BRAIN METASTASES FROM BREAST-CARCINOMA - COMMENTS, Neurosurgery, 43(5), 1998, pp. 1193-1193
SURVIVAL AND FUNCTIONAL STATUS AFTER RESECTION OF RECURRENT GLIOBLASTOMA-MULTIFORME
Authors: BARKER FG CHANG SM GUTIN PH MALEC MK MCDERMOTT MW PRADOS MD WILSON CB
Citation: Fg. Barker et al., SURVIVAL AND FUNCTIONAL STATUS AFTER RESECTION OF RECURRENT GLIOBLASTOMA-MULTIFORME, Neurosurgery, 42(4), 1998, pp. 709-720
HOUSEHOLD HUMAN-IMMUNODEFICIENCY-VIRUS TRANSMISSION RELATED TO PALLIATIVE CARE
Authors: PRADOS MD VICIANA P RODRIGUEZHERNANDEZ MJ PACHON J
Citation: Md. Prados et al., HOUSEHOLD HUMAN-IMMUNODEFICIENCY-VIRUS TRANSMISSION RELATED TO PALLIATIVE CARE, Medicina Clinica, 111(11), 1998, pp. 437-438
ABNORMAL P53 EXPRESSION AND RADIOGRAPHICALLY ASSESSED RADIATION RESPONSE IN GLIOBLASTOMA-MULTIFORME (GM)
Authors: SIMMONS ML BARKER FG PRADOS MD CHANG SM LAMBORN KR WARA WM SNEED PK LARSON DA BOLLEN AW DAVIS RL WILSON CB BERGER MS CHEN P ALDAPE K
Citation: Ml. Simmons et al., ABNORMAL P53 EXPRESSION AND RADIOGRAPHICALLY ASSESSED RADIATION RESPONSE IN GLIOBLASTOMA-MULTIFORME (GM), Journal of neuropathology and experimental neurology, 57(5), 1998, pp. 5-5
PRIMARY CENTRAL-NERVOUS-SYSTEM TUMORS - ADVANCES IN KNOWLEDGE AND TREATMENT
Authors: PRADOS MD BERGER MS WILSON CB
Citation: Md. Prados et al., PRIMARY CENTRAL-NERVOUS-SYSTEM TUMORS - ADVANCES IN KNOWLEDGE AND TREATMENT, Ca, 48(6), 1998, pp. 331
ADULT MEDULLOBLASTOMA - AN ANALYSIS OF SURVIVAL AND PROGNOSTIC FACTORS
Authors: LE QT WEIL MD WARA WM LAMBORN KR PRADOS MD EDWARDS MSB GUTIN PH
Citation: Qt. Le et al., ADULT MEDULLOBLASTOMA - AN ANALYSIS OF SURVIVAL AND PROGNOSTIC FACTORS, The cancer journal from Scientific American, 3(4), 1997, pp. 238-245
PHASE-II TRIAL OF GLI-328 HSV-TK GENE-THERAPY IN RECURRENT GLIOBLASTOMA
Authors: BERGER MS PRADOS MD VANGILDER JC WARNICK RE MCDERMOTT MW MARCUS SG KAPCALA LP
Citation: Ms. Berger et al., PHASE-II TRIAL OF GLI-328 HSV-TK GENE-THERAPY IN RECURRENT GLIOBLASTOMA, Cancer gene therapy, 4(6), 1997, pp. 102-102
ALIGNMENT OF VOLUME MR-IMAGES AND HIGH-RESOLUTION [F-18] FLUORODEOXYGLUCOSE PET IMAGES FOR THE EVALUATION OF PATIENTS WITH BRAIN-TUMORS
Authors: NELSON SJ DAY MR BUFFONE PJ WALD LL BUDINGER TF HAWKINS R DILLON WP HUHN S PRADOS MD CHANG S VIGNERON DB
Citation: Sj. Nelson et al., ALIGNMENT OF VOLUME MR-IMAGES AND HIGH-RESOLUTION [F-18] FLUORODEOXYGLUCOSE PET IMAGES FOR THE EVALUATION OF PATIENTS WITH BRAIN-TUMORS, Journal of computer assisted tomography, 21(2), 1997, pp. 183-191
NEUROPSYCHOLOGICAL SEQUELAE OF MEDULLOBLASTOMA IN ADULTS
Authors: KRAMER JH CROWE AB LARSON DA SNEED PK GUTIN PH MCDERMOTT MW PRADOS MD
Citation: Jh. Kramer et al., NEUROPSYCHOLOGICAL SEQUELAE OF MEDULLOBLASTOMA IN ADULTS, International journal of radiation oncology, biology, physics, 38(1), 1997, pp. 21-26
MINIMAL-CHANGE IGE-MEDIATED GLOMERULONEPH RITIS
Authors: CALLEJAS JL NAVASPAREJO A PRADOS MD CEREZO S
Citation: Jl. Callejas et al., MINIMAL-CHANGE IGE-MEDIATED GLOMERULONEPH RITIS, Nefrologia, 17(6), 1997, pp. 524-525
TREATMENT OF PEDIATRIC LOW-GRADE GLIOMAS WITH A NITROSOUREA-BASED MULTIAGENT CHEMOTHERAPY REGIMEN
Authors: PRADOS MD EDWARDS MSB RABBITT J LAMBORN K DAVIS RL LEVIN VA
Citation: Md. Prados et al., TREATMENT OF PEDIATRIC LOW-GRADE GLIOMAS WITH A NITROSOUREA-BASED MULTIAGENT CHEMOTHERAPY REGIMEN, Journal of neuro-oncology, 32(3), 1997, pp. 235-241
INTERSTITIAL CHEMOTHERAPY WITH CARMUSTINE-LOADED POLYMERS FOR HIGH-GRADE GLIOMAS - A RANDOMIZED DOUBLE-BLIND-STUDY - COMMENT
Authors: PRADOS MD
Citation: Md. Prados, INTERSTITIAL CHEMOTHERAPY WITH CARMUSTINE-LOADED POLYMERS FOR HIGH-GRADE GLIOMAS - A RANDOMIZED DOUBLE-BLIND-STUDY - COMMENT, Neurosurgery, 41(1), 1997, pp. 49-49
TECHNETIUM-MIBI AS A GLIOMA IMAGING AGENT FOR THE ASSESSMENT OF MULTIDRUG-RESISTANCE - COMMENT
Authors: PRADOS MD
Citation: Md. Prados, TECHNETIUM-MIBI AS A GLIOMA IMAGING AGENT FOR THE ASSESSMENT OF MULTIDRUG-RESISTANCE - COMMENT, Neurosurgery, 40(6), 1997, pp. 1334-1334
CHALLENGES IN THE DESIGN AND CONDUCT OF PHASE-III BRAIN-TUMOR THERAPYTRIALS
Authors: PERRY JR DEANGELIS LM SCHOLD SC BURGER PC BREM H BROWN MT CURRAN WJ SCOTT CB PRADOS MD KAPLAN R CAIRNCROSS JG
Citation: Jr. Perry et al., CHALLENGES IN THE DESIGN AND CONDUCT OF PHASE-III BRAIN-TUMOR THERAPYTRIALS, Neurology, 49(4), 1997, pp. 912-917
SERIAL PROTON MAGNETIC-RESONANCE SPECTROSCOPY IMAGING OF GLIOBLASTOMA-MULTIFORME AFTER BRACHYTHERAPY
Authors: WALD LL NELSON SJ RAY MR NOWOROLSKI SE HENRY RG HUHN SL CHANG S PRADOS MD SNEED PK LARSON DA WARA WM MCDERMOTT M DILLON WP GUTIN PH VIGNERON DB
Citation: Ll. Wald et al., SERIAL PROTON MAGNETIC-RESONANCE SPECTROSCOPY IMAGING OF GLIOBLASTOMA-MULTIFORME AFTER BRACHYTHERAPY, Journal of neurosurgery, 87(4), 1997, pp. 525-534
AGE AND THE RISK OF ANAPLASIA IN MAGNETIC RESONANCE-NONENHANCING SUPRATENTORIAL CEREBRAL-TUMORS
Authors: BARKER FG CHANG SM HUHN SL DAVIS RL GUTIN PH MCDERMOTT MW WILSON CB PRADOS MD
Citation: Fg. Barker et al., AGE AND THE RISK OF ANAPLASIA IN MAGNETIC RESONANCE-NONENHANCING SUPRATENTORIAL CEREBRAL-TUMORS, Cancer, 80(5), 1997, pp. 936-941
18-FLUORODEOXYGLUCOSE UPTAKE AND SURVIVAL OF PATIENTS WITH SUSPECTED RECURRENT MALIGNANT GLIOMA
Authors: BARKER FG CHANG SM VALK PE POUNDS TR PRADOS MD
Citation: Fg. Barker et al., 18-FLUORODEOXYGLUCOSE UPTAKE AND SURVIVAL OF PATIENTS WITH SUSPECTED RECURRENT MALIGNANT GLIOMA, Cancer, 79(1), 1997, pp. 115-126
Risultati: 1-25 | 26-50 | 51-63